Boehringer Ingelheim is hosting a live webinar at 7:30pm on Thursday evening (16th April) in which a panel of business experts will offer advice as to how practices can navigate the coronavirus pandemic. 

The webinar will consider questions such as how practices can maintain turnover whilst sticking to the government and regulator guidelines, and how this can be done without compromising the customer experience. 

Hosted by Past President of the British Veterinary Association Gudrun Ravetz, three additional veterinary business experts - Brian Faulkner, Alison Lambert and Alan Robinson - will come together to share their advice on how to minimise the impact that coronavirus has on the practice, the team and a practice’s clients.

Veterinary professionals can submit questions directly to the panel who will answer them during the live event.

To register for the webinar, visit the Boehringer www.boehringer-academy.co.uk.

HRH The Princess Royal has opened the Animal Health Trust's new cancer treatment and research facility in Suffolk.

The facility has been purpose-built to treat horses, dogs and cats with cancer. It will also assist in furthering understanding of the disease in animals.

Peter Webbon, Chief Executive of the AHT, said: "2012 marks 70 years of the AHT fighting disease and injury in animals, and the addition of the Cancer Centre is a landmark achievement in our history. We believe this is the first facility of its kind in Europe, purpose-built to treat horses, dogs and cats with cancer. We now have a short commissioning process to undertake but anticipate welcoming the first patients through the doors in early 2013."

The Kennel Club Cancer Centre at the AHT houses a linear accelerator (pictured right) and brachytherapy machine used in radiotherapy treatment, along with a 16-slice CT scanner to aid radiotherapy planning.

The new facility complements the AHT's existing cancer treatment options of surgery and chemotherapy meaning the Suffolk-based charity will be able to offer each and every patient the very best options for their specific case, whatever the diagnosis.  With one in four dogs and one in six cats developing cancer at some time in their life the new centre will help many more animals fight cancer.

Peter Webbon, added: "It was thanks to a generous donation from the late Tom Scott, a long-term supporter of the AHT, that we were able to start this development. His donation, along with that from many other AHT supporters, and an interest-free loan of £1.5 million from the Kennel Club has meant this ambitious project has come to fruition so quickly."

It has taken just over a year to build the Cancer Centre which contains more than 2,600 tonnes of concrete and has eight-feet wide solid concrete walls.

On opening the facility, HRH The Princess Royal, President of the AHT, said: "This Cancer Centre is an exciting development at the AHT and will make a real difference for animals with cancer, here and now. It will improve the chances, for many animals, of beating this pernicious disease.

"Countless other horses, dogs and cats across the world with cancer, who will never be seen by an AHT clinician, will also benefit from knowledge gained from research in The Kennel Club Cancer Centre at the AHT."

The AHT has a strong history in cancer research and the Kennel Club Cancer Centre will enhance the charity's well established cancer research programme. Knowledge gained through the treatment of animals in the facility will contribute to the study of cancers, their causes, early diagnosis and treatment, and ultimately hopefully the prevention of some forms of the disease.

Steve Dean, Kennel Club Chairman, said: "I am very proud to be here today to celebrate the opening of the Kennel Club Cancer Centre. Thanks to the expertise available here at the Animal Health Trust, the Cancer Centre will provide advanced techniques for the diagnosis and treatment of cancer, to the benefit of many animals.  It is exciting to consider how synergy between the Kennel Club Cancer Centre and the Kennel Club Genetics Centre can help to further the understanding of the inheritance factors that influence the development of cancer."

Diagnostics testing company MI:RNA has developed an AI-powered test for Johne's disease in cattle, with a claimed accuracy of 73% sensitivity, 71% specificity and 72% accuracy, which are expected to improve with further research. 

MI:RNA says that current testing practices for Johne’s disease mean that identification of the disease is difficult, with current sensitivities of around 10-40% and little to no ability to diagnose early stages of infection.

The loss of productivity due to Johne’s to the UK agricultural economy is estimated to be in excess of £10 million annually.

MI:RNA says it is the first diagnostic testing company to use microRNA assay technology.

MicroRNAs are newly discovered biomarkers that manage the immune system and immune responses and act as regulators for disease progression or resolution.

This, says the company, makes them excellent biomarkers of disease, and when combined AI, can significantly improve identification of Johne’s and other complex conditions, and predict disease outcomes.

MI:RNA says this development will allow veterinary surgeons, farmers and pet owners to test for a variety of conditions, not just Johne’s.

Target areas include heart and kidney disease, osteoarthritis and bovine tuberculosis, along with effective general wellness and preoperative screening.

Eve Hanks, founder and CEO of MI:RNA, said: “Increasing market and global pressures on bovine protein production means that animal health has never been more important.

"This is a key area of research and development for MI:RNA and biomarker science combined with our unique AI-powered modelling, means that we can significantly improve animal health and reduce greenhouse gas output.

“The breakthrough that we’ve already achieved in Johne’s testing is unparalleled, and has provided an opportunity for MI:RNA to pitch our business concept in the USA to the The Kansas City Animal Health Summit.

"Following our presentation, we have now progressed through to the final selection stage for European Innovation Council funding for our work on Johne’s disease. 

“In terms of future applications, microRNAs can assist with vital drug discovery, progressing future diagnostic testing and understanding disease pathways more effectively.

"We’ve already made remarkable progress and we know that with the continued backing of our tech, AI and health experts and with the correct funding, that we can do so much more.” 

BCF, the veterinary imaging company, has launched a competition in which you can test your knowledge on a series of x-ray and ultrasound images for the chance to win a Sony Cyber Shot digital camera.

Visit the BCF website to enter - www.bcftechnology.com/

Entries to be in by 31^st May 2011 and the winner will be drawn at random on the 6^th of June 2011.

Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.

The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.

Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.

Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."

According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin. 

Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."

In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com

Brian Cullen Bowles has been struck off by the RCVS Disciplinary Committee after he was found to have put public health at risk by dishonestly certifying cattle test results.

Mr Bowles faced four charges, but did not respond to the College's notification about the hearing, so the Committee decided to proceed in his absence.

The first charge was that in 2020, while attending a farm in Lincolnshire in his capacity as an Official Veterinarian (OV), Mr Bowles carried out Intradermal Comparative Tuberculin (ICT) tests on a herd of cattle but failed to measure the skin thickness of all the cattle using callipers and failed to take and record measurements for the cattle.

The Committee was provided with evidence that Mr Bowles had, in earlier correspondence with the College, admitted that he had failed to follow Animal and Plant Health Agency (APHA) standard operating procedures for ICT testing at the farm and so the charge was found proven.

The second charge was that he then certified the results of the inaccurate ICT test he'd performed earlier.

The Committee found this charge proven on the basis that, without using callipers to measure skin thickness, he was not entitled to certify the test.

The third charge was that his conduct in relation to the first two charges was dishonest, misleading and risked undermining government testing procedures designed to promote public health and animal welfare.

The Committee found all elements of the charges proven.

The final charge was that Mr Bowles's conduct took place despite warnings, advice and re-training being given by the APHA.

These included: a letter sent to Mr Bowles’s by APHA in 2014 about the suspension of his OV status after he failed to comply with APHA rules; a letter sent by the APHA to Mr Bowles’s employer in October 2016 regarding issues of non-compliance it had found during a September 2016 audit; and the suspension of Mr Bowles’s OV duties by his employer, pending further training, following issues of non-compliance.

Given Mr Bowles’s history of non-compliance with APHA standard operating procedures and standards, the Committee found the charge proven.

The Committee found that charges 1 to 3 amounted to serious professional misconduct but that charge 4, while making the conduct in the other charges more serious, did not in and of itself constitute serious professional misconduct.

In determining the most appropriate sanction for Mr Bowles, the Committee found that he had paid ‘scant regard’ to the testing procedures set out by APHA and breached the RCVS certification requirements set out in the Code of Professional Conduct for Veterinary Surgeons in ‘numerous and serious’ ways.

Hilary Lloyd, chairing the Committee and speaking on its behalf, said: “The Committee’s view is that the respondent’s conduct in refusing to follow the OV Instructions when testing cattle in May 2020 constituted conduct of an egregious kind.

"In addition, there are several aggravating elements which can be applied to his misconduct, including a risk to animal or human health; his lack of probity and integrity in certifying test results which he knew were non-compliant and unreliable; recklessness in reaching a conscious decision to ignore the OV Instructions; his failure to comply with the requirements of the position of trust and responsibility which attached to his APHA authorisation; and against a backdrop of sustained pattern of behaviour that displayed blatant disregard of the system that regulated TB testing by OVs.

"It follows that the respondent manifested no insight into the seriousness of his misconduct when acting as an OV.”

The Committee considered whether there were any mitigating factors regarding Mr Bowles’ conduct.

It took into account that Mr Bowles had not secured any financial advantage, that there was no actual harm to animals, and that he had a long career as a veterinary surgeon, although with a history of non-compliance.

It noted that there had been some late admissions of misconduct by Mr Bowles when he tendered an apology, but found this mitigation was undermined by the fact his explanations lacked consistency and that he had also initially asserted that he had used callipers during the testing.

Due to the seriousness of the non-compliance, the dishonesty and the potential risk to public health, the Committee considered that removing Mr Bowles from the Register was the only proportionate and appropriate response to the scale of misconduct.

Hilary added: “Given the amount of advice received and re-training which the respondent was required to undertake, he has already had ample opportunity to remediate his practice but has not done so.

"The Committee is therefore concerned that there is a very real risk of further repetition of this conduct in the future were he to be permitted to remain on the Register.

“The Committee’s concern in this regard stems from the fact that the dishonesty of which the respondent has been found guilty, was not dishonesty committed on the spur of the moment.

"The respondent had ample opportunities for reflection before resolving to act as he did.

"This places his acts of dishonesty in the most serious category.

“The public is entitled to expect that it can have confidence in the certifications of a veterinary surgeon who is carrying out a public duty on behalf of that public body.

"Indeed, that is the whole purpose behind the requirement that OVs undertake additional and specialised training before being permitted to undertake OV duties.”

www.rcvs.org.uk/disciplinary

MSD Animal Health's equine division has launched a new series of materials to support its Keeping Britain's Horses Healthy Campaign.

For veterinary practices, there's a Vet Reception Pack designed to help receptionists educate owners why they should vaccinate and the benefits of preventive healthcare.

For yards, there are posters giving guidance and advice on prevention of Infectious Respiratory Disease and the steps which should be taken to control a potential outbreak. They can be tailor made for an individual yard.  

Peter Young, MSD Animal Health Equine Business Manager said: "Our first wave of support materials focused very much on equine vets and owners - helping raise awareness of the importance of preventive healthcare and driving owners towards vets for advice. This phase of materials helps support yard owners and receptionists, aiming to fill some of those communications gaps where advice and guidelines on individual horse's vaccination requirements and yard protocols can play a vital role in preventing the spread of disease and controlling outbreaks."  

Keeping Britain's Horses Healthy is a national campaign to educate horse owners on endemic infectious disease, vaccination, herd immunity and the importance of preventative healthcare. It includes a range of educational materials for veterinary surgeries and direct to owners. The campaign is supported by a national PR, advertising and social media programme, together with a dedicated website www.healthyhorses.co.uk.  The website, aimed at driving owners back to their veterinary practices, includes a vet finder, exclusively for equine practices, and healthcare information.  

For full details of the launch programme, talk to your account manager, call 01908 685685 or visit www.healthyhorses.co.uk. 

A new animal welfare report by the PDSA has revealed that millions of pets are more aggressive, overweight and misunderstood than ever due to fundamental gaps in pet owners' animal welfare knowledge.

The PDSA Animal Wellbeing (PAW) report, which captures the views of pet owners, the veterinary profession and children, reveals that 1.3 million dogs across the UK are displaying problem behaviour. It also highlights the consequences of an obesity epidemic affecting 18.5 million dogs, cats and rabbits, and draws attention to the 11.2 million pets not registered with a vet and therefore at risk of disease due to not being vaccinated or neutered.

The BVA is urging veterinary surgeons and nurses to read the report which identifies where owners are misinformed or unaware and highlights areas that everyone can work on with their clients to help achieve better wellbeing for pets. 

Peter Jones, President of the BVA, said: "This is another excellent report from the PDSA offering real insight into clients' motivations. Understanding what drives owners' attitudes, as well as helping them to understand key health and welfare issues, should help us to clarify misconceptions in the consulting room and hopefully change behaviour at home.

"On the positive side, with pet obesity ever rising it is good to see that there is a slight increase in the proportion of owners starting to recognise obesity in their pets. This is, no doubt, in part due to the tireless work of charities like the PDSA and the veterinary profession as a whole. 

"Sadly, despite most owners' awareness of the ill effect that bad nutrition has on their pet this has not led to them cutting out pet treats. The fact that few can identify a healthy body shape shows that much remains to be done.

"The section on preventive healthcare remains worrying with many owners seemingly not believing in the concepts of microchipping, neutering and vaccination. Vets have a real responsibility to help communicate these issues to the pet owning public for the benefit of both clients and their animals.

"The report very clearly identifies where owners are misinformed or unaware and highlights areas that vets in practice can work on with their clients to help achieve better wellbeing for pets. 

"The report is very clearly laid out and well worth a read. We would encourage all vets to take a look and identify any new educational resources to promote in the practice, in newsletters and on websites in addition to the ones they already make available to clients. The AWF leaflets, the PDSA's own website, and the Education Alliance are all good starting points."

Click here for the report.

The Equine Veterinary Journal has published a free special collection of new research on Equine Grass Sickness this month.

Four separate studies are included in the collection, reporting novel risk factors for the disease, identifying key differences between EGS and botulism (questioning the hypothesis that EGS is caused by neurotoxins from Clostridium botulinum), reporting a novel diagnostic technique and showing the value of monitoring weight loss to help predict whether individual horses with chronic EGS are likely to survive.

The publishers say that despite more than 100 years of research, supported predominantly by the The Moredun Foundation Equine Grass Sickness Fund (www.grasssickness.org.uk), the cause of EGS remains unknown. Since it almost exclusively affects grazing horses, a pasture derived neurotoxin is implicated. EGS causes gut paralysis as a result of damage to parts of the nervous system that control involuntary functions. Acute and sub-acute EGS is invariably fatal while around 55% of chronic cases can survive and return to a useful working life. The UK has the highest incidence of EGS in the world; indeed it is estimated that the disease kills between 1 and 2% of horses in the United Kingdom annually. Cases are more common in spring.

In terms of risk factors, the study ‘Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors’ suggests that the high incidence of the disease in Eastern Scotland may be partly associated with the particular composition of macro and trace elements in the soil in the fields on which horses graze. Further work is required to determine whether interventions to alter concentrations of particular elements in soil could potentially reduce the risk of EGS.¹

A second study identified key differences between EGS and botulism, which questions the currently favoured hypothesis that EGS is caused by neurotoxins from Clostridium botulinum, a bacterium which commonly inhabits soil. The study ‘Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya’ suggests that EGS is unlikely to be caused by neurotoxins from this bacterium and concludes that further investigation of an alternative cause for EGS is needed.²

While the majority of horses with EGS can be readily diagnosed by experienced veterinary surgeons, some cases present a diagnostic challenge. Indeed the only way to definitively diagnose the disease in a live horse is to demonstrate the characteristic degeneration of nerves within biopsies of the intestine. Unfortunately these biopsies can only be collected by performing abdominal surgery under general anaesthesia. In the study ‘Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness’ characteristic degeneration of nerves was identified in small biopsies collected from tongues of EGS horses during post mortem examination. Examination of these biopsies accurately differentiated control horses from EGS cases. While further validation of this technique is required, it could potentially provide a relatively non-invasive method of confirming the diagnosis in a live horse.³

While around 55% of horses with chronic EGS survive, objective criteria for predicting survival of these cases are currently lacking. The study ‘Bodyweight change aids prediction of survival in chronic equine grass sickness’ reported that non-survivors had greater rate and magnitude of bodyweight loss than survivors. Survival prediction curves were published to allow veterinary surgeons and horse owners to use body weight data to help determine whether an individual horse with chronic EGS was likely to survive or die.⁴

Professor Bruce McGorum, Head of the Equine Section at the Royal (Dick) School of Veterinary Studies & Roslin Institute in Edinburgh, has been leading much of the research. He said: "Given that our recent research suggests that EGS is unlikely to be caused by neurotoxins from Clostridium botulinum we are now moving on to determine whether EGS is caused by ingestion of mycotoxins produced by pasture fungi. We are very pleased that The Horse Trust (www.horsetrust.org.uk) has provided funding for this three-year investigation."

Professor Celia Marr, Editor of the Equine Veterinary Journal said: “While the cause of equine grass sickness continues to evade us, these papers present an optimistic step in the right direction for the eventual prevention of this dreadful disease. It is only with the support of the Moredun Foundation Equine Grass Sickness Fund and more recently that of The Horse Trust that our world-leading veterinary researchers are able to continue to unravel the mystery.”

The EVJ equine grass sickness collection can be downloaded at http://bit.ly/2dC7Drr

References

1. Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors C. E. Wylie, D. J. Shaw, F. M. Fordyce, A. Lilly, R. S. Pirie, B. C. McGorum
2. Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya B. C. McGorum, S. Scholes, E. M. Milne, S. L. Eaton, T. M. Wishart, R. Poxton, S. Moss, U. Wernery, T. Davey, J. B. Harris, R. S. Pirie
3. Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness B. C. McGorum, R. S. Pirie, D. Shaw, N. Macintyre, A. Cox
4. Bodyweight change aids prediction of survival in chronic equine grass sickness R. C. Jago, I. Handel, C. N. Hahn, R. S. Pirie, J. A. Keen, B. E. Waggett, B. C. McGorum

The BVA is now reaching out to non-members with a three-month, no strings attached, free trial. The offer ends on 31 August.

Over the past few years the BVA membership package has changed significantly in response to the needs of veterinary surgeons across the UK at all stages of their careers.

Harvey Locke, BVA President, said: "The well-documented stresses that put members of our profession at risk of mental health problems are unacceptably high. With their focus on conflict resolution and individual support, however, we hope the BVA legal services will come to be seen as a safety net for BVA members should things go wrong at work.

"These kinds of employment issues can be hard to talk about so we hope by highlighting a few stories it will encourage others to seek the help they need from the BVA.

"The three-month free trial is an opportunity for the BVA to reach out to non-members and show them the impact of our complete membership package - from the legal and employment services and free and discounted CPD to our popular publications and money-saving financial services."